Ledger.Open graph →
SEC Form D · filed January 8, 2018

Reneo Pharmaceuticals, Inc

Offering
$52.0M
Sold
$22.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Michael Grey · San Diego, CAExec · DirectorWendy Johnson · San Diego, CAExecEd Mathers · Austin, TXDirectorMichael R. Ross · Salt Lake City, UTExec · DirectorScott Weiner · Montreal, Quebec, CanadaDirectorNiall O'Donnell · San Diego, CAExec · DirectorMicaela Kelley · London, United KingdomExec · DirectorScott Weiner · Montreal, Quebec, CanadaDirectorWendy Johnson · San Diego, CAExecNiall O'Donnell · San Diego, CAExec · DirectorEd Mathers · Baltimore, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗